Madrigal Pharmaceuticals, Inc.
Status: Publicly traded
Direct answer
Madrigal Pharmaceuticals, Inc. is publicly traded on NASDAQ under the ticker MDGL.
Madrigal Pharmaceuticals, Inc. is a biopharmaceutical company in the clinical development phase, concentrating its efforts on discovering and commercializing innovative treatments for cardiovascular, metabolic, and liver disorders. Its most advanced drug candidate, resmetirom, functions as a liver-targeted selective thyroid hormone receptor-ß agonist, currently undergoing late-stage (Phase III) clinical trials for...
Can you invest in Madrigal Pharmaceuticals, Inc.?
Yes. Madrigal Pharmaceuticals, Inc. is publicly traded on NASDAQ under the ticker MDGL.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Madrigal Pharmaceuticals, Inc.
Detailed equity research is provided by MarketSnap.